Southeast Asia’s first GMP-compliant CDMO CellVec enters strategic partnership with Peter MacCallum Cancer Centre
SINGAPORE, 30 September 2021 – Southeast Asia’s first GMP-compliant CDMO for viral vector manufacturing CellVec Pte Ltd announces today a strategic partnership with Australia’s Peter MacCallum Cancer Centre (Peter Mac) to manufacture and supply lentiviral vectors for their in-house pipeline...